Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,295 INR | -0.60% | +0.30% | -4.54% |
24/05 | Caplin Point Arm Gets US FDA's Nod for Phenylephrine Hydrochloride Ophthalmic Solution | MT |
16/05 | Caplin Point Laboratories to Seek Acquisitions | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.54% | 119.07Cr | |
+16.40% | 4.29TCr | |
+16.32% | 2.14TCr | |
+19.88% | 1.51TCr | |
+18.64% | 1.44TCr | |
+53.58% | 1.3TCr | |
-0.05% | 678.76Cr | |
-12.64% | 672.16Cr | |
-8.87% | 572.55Cr | |
+11.21% | 546.52Cr |
- Stock Market
- Equities
- CAPLIPOINT Stock
- News Caplin Point Laboratories Limited
- Transcript : Caplin Point Laboratories Limited, Q1 2022 Earnings Call, Aug 06, 2021